Galera Therapeutics, Inc. (GRTX) Financials

GRTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 37.8 million 164.3 million
2023-06-30 48.3 million 163.3 million
2023-03-31 59.7 million 157.3 million
2022-12-31 44.0 million 153.2 million

GRTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -12.5 million 1.4 million
2023-06-30 -10.8 million 1.5 million
2023-03-31 -11.7 million 1.5 million
2022-12-31 -13.9 million 1.7 million

GRTX Net Income

No data available :(

GRTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 28.4 million - 1.3 million
2023-06-30 38.8 million - 1.3 million
2023-03-31 47.8 million - -
2022-12-31 31.6 million - 44000

GRTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 45.5 million
2023-06-30 42.9 million
2023-03-31 35.2 million
2022-12-31 27.9 million

GRTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.1 million 5.0 million -
2023-06-30 50000 7.6 million 9.2 million -
2023-03-31 50000 7.3 million 6.6 million -
2022-12-31 50000 8.1 million 5.0 million -

GRTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 12000
2023-06-30 - 12000
2023-03-31 - 20000
2022-12-31 - 26000

GRTX

Price: $0.19

52 week price:
0.09
3.59

Earnings Per Share: -1.88 USD

P/E Ratio: -0.09

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 52746

Market Capitalization: 9.0 million

Links: